Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Outcome after Neuro-interventional Treatment of Intracranial Aneurysm (as a First Treatment Modality)

H. Ghanaati, A. Rahmatian, M. R. Amiri-Nikpour, D. Altafi, M. Taheri, S. B. Siroos, M. Shakiba, R. Elahi, M. A. Avanaki

. 2024 ; 125 (1) : 15-33. [pub] -

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24009839

Endovascular treatment is widely applied as the first-line treatment for intracranial aneurysms and includes simple coiling (SC), stent-assisted coiling (SAC), flow diversion stent, and flow disruption stent. The present study is a retrospective cohort study performed in Imam Khomeini Hospital, Department of Neurovascular Intervention, between March 2016 and March 2021. A total number of 229 patients with intracranial aneurysms who underwent therapeutic intravascular interventions were enrolled, of which 89 were treated with SC, 111 with SAC, 25 with flow diversion stent, and 4 with flow disruption stent. The mean age of the subjects was 51.8±12.6 years, and 51.1% were male. Modified Raymond-Roy classification (MRRC) was used to define the occlusion outcome. The success rate, considered as Class I and Class II of MRRC at treatment time was 89% (94.4% in SC, and 84.7% in SAC), which was increased to 90.9% (94% in SC, 93% in SAC, 69.6% in flow diversion stenting, 100% in flow disruption) at 6-month follow-up, and 84.6% (80.8% in SC, 87.8% in SAC, 78.3% in flow diversion stenting, and 100% in flow disruption) at 12-month follow-up. The mean modified Rankin Scale (mRS) before the procedure was 0.05±0.26 which was increased to 0.22±0.76 after the procedure, 0.22±0.76 at 6 months, and 0.30±0.95 at 12 months (P<0.001). Similar to previous studies, the present study demonstrates that neurovascular intervention can treat ruptured aneurysms as the first therapeutic modality with favourable outcomes. A double-blind, randomized clinical trial is needed to eliminate the confounding factors and better demonstrate the outcome.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24009839
003      
CZ-PrNML
005      
20250423091351.0
007      
ta
008      
240606s2024 xr f 000 0|eng||
009      
AR
024    7_
$a 10.14712/23362936.2024.2 $2 doi
035    __
$a (PubMed)38380451
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Ghanaati, Hossein $u Advanced Diagnostic and Interventional Radiology Research Center (ADIR), Emam-Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
245    10
$a Outcome after Neuro-interventional Treatment of Intracranial Aneurysm (as a First Treatment Modality) / $c H. Ghanaati, A. Rahmatian, M. R. Amiri-Nikpour, D. Altafi, M. Taheri, S. B. Siroos, M. Shakiba, R. Elahi, M. A. Avanaki
520    9_
$a Endovascular treatment is widely applied as the first-line treatment for intracranial aneurysms and includes simple coiling (SC), stent-assisted coiling (SAC), flow diversion stent, and flow disruption stent. The present study is a retrospective cohort study performed in Imam Khomeini Hospital, Department of Neurovascular Intervention, between March 2016 and March 2021. A total number of 229 patients with intracranial aneurysms who underwent therapeutic intravascular interventions were enrolled, of which 89 were treated with SC, 111 with SAC, 25 with flow diversion stent, and 4 with flow disruption stent. The mean age of the subjects was 51.8±12.6 years, and 51.1% were male. Modified Raymond-Roy classification (MRRC) was used to define the occlusion outcome. The success rate, considered as Class I and Class II of MRRC at treatment time was 89% (94.4% in SC, and 84.7% in SAC), which was increased to 90.9% (94% in SC, 93% in SAC, 69.6% in flow diversion stenting, 100% in flow disruption) at 6-month follow-up, and 84.6% (80.8% in SC, 87.8% in SAC, 78.3% in flow diversion stenting, and 100% in flow disruption) at 12-month follow-up. The mean modified Rankin Scale (mRS) before the procedure was 0.05±0.26 which was increased to 0.22±0.76 after the procedure, 0.22±0.76 at 6 months, and 0.30±0.95 at 12 months (P&lt;0.001). Similar to previous studies, the present study demonstrates that neurovascular intervention can treat ruptured aneurysms as the first therapeutic modality with favourable outcomes. A double-blind, randomized clinical trial is needed to eliminate the confounding factors and better demonstrate the outcome.
650    _2
$a dospělí $7 D000328
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    12
$a terapeutická embolizace $x metody $7 D004621
650    12
$a endovaskulární výkony $x metody $7 D057510
650    12
$a intrakraniální aneurysma $x terapie $7 D002532
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a stenty $7 D015607
650    _2
$a výsledek terapie $7 D016896
655    _2
$a časopisecké články $7 D016428
700    1_
$a Rahmatian, Aryoobarzan $u Department of Neurology, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran $u Iranian Center of Neurological Research, Department of Neurovascular Intervention, Tehran University of Medical Sciences, Tehran, Iran
700    1_
$a Amiri-Nikpour, Mohammad Reza $u Iranian Center of Neurological Research, Department of Neurovascular Intervention, Tehran University of Medical Sciences, Tehran, Iran. reza.nikpor@gmail.com
700    1_
$a Altafi, Davar $u Iranian Center of Neurological Research, Department of Neurovascular Intervention, Tehran University of Medical Sciences, Tehran, Iran
700    1_
$a Taheri, Morteza $u Iranian Center of Neurological Research, Department of Neurovascular Intervention, Tehran University of Medical Sciences, Tehran, Iran $u Iran University of Medical Sciences, Tehran, Iran
700    1_
$a Siroos, Seyed Bahaadin $u Iranian Center of Neurological Research, Department of Neurovascular Intervention, Tehran University of Medical Sciences, Tehran, Iran
700    1_
$a Shakiba, Madjid $u Advanced Diagnostic and Interventional Radiology Research Center (ADIR), Emam-Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
700    1_
$a Elahi, Reza $u Advanced Diagnostic and Interventional Radiology Research Center (ADIR), Emam-Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
700    1_
$a Avanaki, Mahsa Alborzi $u Advanced Diagnostic and Interventional Radiology Research Center (ADIR), Emam-Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
773    0_
$w MED00013414 $t Prague medical report $x 1214-6994 $g Roč. 125, č. 1 (2024), s. 15-33
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38380451 $y Pubmed
910    __
$a ABA008 $b A 7 $c 1071 $y p $z 0
990    __
$a 20240606 $b ABA008
991    __
$a 20250423091351 $b ABA008
999    __
$a ok $b bmc $g 2307228 $s 1219669
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 125 $c 1 $d 15-33 $e - $i 1214-6994 $m Prague medical report $n Prague Med Rep $x MED00013414
LZP    __
$b NLK124 $a Pubmed-20240606

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace